Review article · 2026

Bacteriophage therapy for multidrug-resistant bacterial infections: recent advances, clinical evidence, and translational challenges

Sushama Agarwalla

Archives of Microbiology, 208(9) · Published 12 June 2026 · DOI 10.1007/s00203-026-04980-w

View at the publisherCite this paper

In brief

“Bacteriophage therapy for multidrug-resistant bacterial infections: recent advances, clinical evidence, and translational challenges” is a 2026 review article by Sushama Agarwalla, published in Archives of Microbiology. OpenAlex counts 0 citations as of 15 November 2026, which puts it in the top 9% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
Field-weighted impact
0.64
References
139
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Agarwalla, S. (2026). Bacteriophage therapy for multidrug-resistant bacterial infections: recent advances, clinical evidence, and translational challenges. Archives of Microbiology, 208(9). https://doi.org/10.1007/s00203-026-04980-w

MLA 9

Agarwalla, Sushama. “Bacteriophage therapy for multidrug-resistant bacterial infections: recent advances, clinical evidence, and translational challenges.” Archives of Microbiology, vol. 208, no. 9, 2026. https://doi.org/10.1007/s00203-026-04980-w.

Chicago

Agarwalla, Sushama. 2026. “Bacteriophage therapy for multidrug-resistant bacterial infections: recent advances, clinical evidence, and translational challenges.” Archives of Microbiology 208 (9). https://doi.org/10.1007/s00203-026-04980-w.

Harvard

Agarwalla, S. (2026) ‘Bacteriophage therapy for multidrug-resistant bacterial infections: recent advances, clinical evidence, and translational challenges’, Archives of Microbiology, 208(9). doi:10.1007/s00203-026-04980-w.

IEEE

S. Agarwalla, “Bacteriophage therapy for multidrug-resistant bacterial infections: recent advances, clinical evidence, and translational challenges,” Archives of Microbiology, vol. 208, no. 9, 2026, doi: 10.1007/s00203-026-04980-w.

BibTeX

@article{agarwalla2026bacteriophage,
  title     = {{Bacteriophage therapy for multidrug-resistant bacterial infections: recent advances, clinical evidence, and translational challenges}},
  author    = {Agarwalla, Sushama},
  journal   = {Archives of Microbiology},
  year      = {2026},
  volume    = {208},
  number    = {9},
  doi       = {10.1007/s00203-026-04980-w},
  url       = {https://doi.org/10.1007/s00203-026-04980-w}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions

  • phage therapy
  • multidrug-resistant bacterial infections
  • endolysin
  • depolymerase
  • phage resistance
  • host immune response
  • neutralizing antibodies
  • phage-antibiotic synergy

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Agarwalla, S. (2026). Bacteriophage therapy for multidrug-resistant bacterial infections: recent advances, clinical evidence, and translational challenges. Archives of Microbiology, 208(9). https://doi.org/10.1007/s00203-026-04980-w

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Sushama Agarwalla.

What is the DOI of this paper?

10.1007/s00203-026-04980-w. The permanent link is https://doi.org/10.1007/s00203-026-04980-w.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.